GRASSI, ELISA STELLARIA
 Distribuzione geografica
Continente #
AS - Asia 2.075
NA - Nord America 1.922
EU - Europa 1.723
SA - Sud America 180
AF - Africa 41
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.953
Nazione #
US - Stati Uniti d'America 1.840
CN - Cina 775
SG - Singapore 573
IT - Italia 428
GB - Regno Unito 332
DE - Germania 320
HK - Hong Kong 160
VN - Vietnam 157
BR - Brasile 144
SE - Svezia 135
BD - Bangladesh 120
RU - Federazione Russa 107
IN - India 91
NL - Olanda 87
FR - Francia 61
FI - Finlandia 59
CA - Canada 53
DK - Danimarca 44
JP - Giappone 37
ID - Indonesia 36
KR - Corea 29
IE - Irlanda 28
TR - Turchia 21
ES - Italia 17
UA - Ucraina 16
MX - Messico 15
CH - Svizzera 13
PL - Polonia 13
AR - Argentina 12
PK - Pakistan 12
BE - Belgio 11
AT - Austria 9
AU - Australia 9
CI - Costa d'Avorio 9
EC - Ecuador 9
IR - Iran 9
GR - Grecia 7
PH - Filippine 7
SK - Slovacchia (Repubblica Slovacca) 7
TW - Taiwan 7
PT - Portogallo 6
TH - Thailandia 6
UZ - Uzbekistan 6
AL - Albania 5
CZ - Repubblica Ceca 5
TN - Tunisia 5
ZA - Sudafrica 5
CO - Colombia 4
EG - Egitto 4
IQ - Iraq 4
JM - Giamaica 4
KE - Kenya 4
NP - Nepal 4
SC - Seychelles 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
CL - Cile 3
GT - Guatemala 3
NG - Nigeria 3
NO - Norvegia 3
PY - Paraguay 3
VE - Venezuela 3
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
PE - Perù 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
LT - Lituania 1
LY - Libia 1
MG - Madagascar 1
MW - Malawi 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.953
Città #
Singapore 331
Ashburn 258
Southend 247
Milan 145
Hong Kong 139
Hanover 127
San Jose 122
Chandler 121
Shanghai 121
Fairfield 108
Beijing 78
Dallas 78
Wilmington 78
Council Bluffs 77
Santa Clara 71
Hefei 70
Los Angeles 69
Seattle 61
Frankfurt am Main 56
Ho Chi Minh City 53
Ann Arbor 50
Woodbridge 48
Suzhou 44
Hanoi 43
Helsinki 41
Cambridge 39
Ealing 39
New York 38
Houston 37
Jakarta 33
Princeton 31
Bengaluru 30
Dublin 28
Tokyo 27
Guangzhou 25
Moscow 25
Boardman 23
Lauterbourg 23
Munich 22
Nanjing 21
Kent 19
Seoul 19
Buffalo 18
Chicago 18
Grafing 17
Bologna 16
Naples 16
Toronto 16
Columbus 15
Nuremberg 15
Phoenix 15
Cangzhou 14
The Dalles 14
São Paulo 13
Hangzhou 12
Da Nang 11
Des Moines 11
Istanbul 11
Shenzhen 11
Berlin 10
Brussels 10
Düsseldorf 10
Montreal 10
Rome 10
Abidjan 9
Atlanta 9
Besnate 9
Dearborn 9
Falls Church 9
Florence 9
London 9
Ottawa 9
Zhengzhou 9
Mannheim 8
Rio de Janeiro 8
Shenyang 8
Tehran 8
Wuhan 8
Athens 7
Bernolákovo 7
Central 7
Haiphong 7
Redwood City 7
Warsaw 7
West Drayton 7
Jinan 6
Madison 6
Nanchang 6
Salt Lake City 6
San Diego 6
Tianjin 6
Washington 6
Can Tho 5
Castronno 5
Champaign 5
Elk Grove Village 5
Fremont 5
Fuzhou 5
Guayaquil 5
Kingston 5
Totale 3.660
Nome #
Role of epigenetic therapy in the modulation of tumor growth and migration in human castration-resistant prostate cancer cells with neuroendocrine differentiation 679
Thyrotropin receptor p.N432D retained variant is degraded through an alternative lysosomal/autophagosomal pathway and can be functionally rescued by chemical chaperones 349
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 323
P53 AND MICROTUBULES TARGETING AS A NOVEL STRATEGY WITH POTENTIAL FOR TREATMENT OF AGGRESSIVE POORLY DIFFERENTIATED THYROID CANCER. 314
SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways 295
Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas 286
8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms 282
Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors 276
Stochastic epigenetic mutations as possible explanation for phenotypical discordance among twins with congenital hypothyroidism 231
Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation 226
Tumor and normal thyroid spheroids : from tissues to zebrafish 215
FAM83B is involved in thyroid cancer cell differentiation and migration 197
Loss-of-function variants in a Hungarian cohort reveal structural Insights on TSH receptor maturation and signaling 194
Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies 185
8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth 170
Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma 169
Niche-derived soluble DLK1 promotes glioma growth 166
Patient-Derived in vitro models for unraveling medullary thyroid cancer microenvironment and therapy resistance 165
Targeting the DNA damage response kinase Chk1 in TP53-mutated aggressive thyroid cancers: in vitro studies 160
Extra-nuclear TERT counteracts oxidative stress and promotes progression in papillary thyroid carcinoma 139
Multicellular spheroids: a new model to screen novel drugs for incurable forms of thyroid cancer 139
Three-dimensional multicellular spheroids: an alternative model to screen new drugs for incurable forms of thyroid cancer 133
Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart 126
Three-dimensional spheroids: a new approach for the identification and characterization of novel markers for tumor-initiating cells subpopulations in thyroid cancer 122
The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines 122
The extracellular matrix actively influence thyroid cancer cells sensitivity to TKIS 115
Targeting the DNA damage response kinase CHK1 in TP53-mutated thyroid cancer: in vitro studies 110
Characterization of epcam in thyroid cancer biology by three-dimensional spheroids in vitro model 96
CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells 85
Patient-Derived in Vitro Models Reveal Insights into Medullary Thyroid Cancer Microenvironment and Resistance to Tyrosine Kinase Inhibitors 53
The CHK1 inhibitor Prexasertib is effective against in vitro models of aggressive thyroid carcinomas with defective p53 function 14
The length of FOXE1 polyalanine tract in congenital hypothyroidism: Evidence for a pathogenic role from familial, molecular and cohort studies 7
Totale 6.143
Categoria #
all - tutte 16.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022523 29 27 23 23 26 23 50 53 86 64 61 58
2022/2023443 54 57 31 46 48 67 10 30 42 17 25 16
2023/2024468 15 23 21 40 73 26 19 24 25 59 54 89
2024/20251.150 77 126 33 97 60 57 57 113 79 146 95 210
2025/20262.409 218 200 219 228 236 185 267 112 178 143 226 197
2026/202776 76 0 0 0 0 0 0 0 0 0 0 0
Totale 6.143